CryoPort, Inc. to Present at the Ludlow Biotech Investor Conference in New York City

* Reuters is not responsible for the content in this press release.

Tue May 20, 2008 9:40am EDT 

  LAKE FOREST, CA, May 20 (MARKET WIRE) -- 
 CryoPort, Inc. (OTCBB: CYRX),  a company developing leading edge, proprietary,
technology-driven shipping and storage products for use in the rapidly
growing global biotechnology and biopharmaceutical cold chain,  today
announced plans for the company to present at the Ludlow Biotech Investor
Conference Thursday, May 22, 2008.

    The conference will be held at the New York Helmsley Hotel in New York City,
between 5pm to 8pm EDT.

    Investors interested in attending can register online here --
http://www.ludlowcapital.com/events/attend.html

    About Ludlow Biotech Ventures, Inc.

    Headquartered in Manhattan, Ludlow BioVentures, Inc. is a full service
investment
advisory firm which serves the needs of both private and public biotechnology
companies. Our simple approach is to provide customized financial solutions for
virtually any of our clients needs. www.ludlowcapital.com/bioventures/

    About CryoPort, Inc.

    CryoPort's mission is to provide the most cost effective packaging system
that
ensures conservation of temperature sensitive biological materials that are
critical to the expanding biopharmaceutical and biotechnology industries.
CryoPort is
dedicated to producing superior, affordable cryogenic shipping systems that
maintains the integrity of scientific research advanced by the growing biopharma
and
biotech industries. CryoPort understands the value of such research and is
committed to evolving cryogenic shipping as a new industry standard globally for
temperaturesensitive materials; such as life-sustaining vaccines and other
medical research
that are used in clinical trials around the world.

    "SAFE HARBOR"

    This press release contains forward-looking statements. The words
"estimate,"
"possible" and "seeking" and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made. The company
undertakes no obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified. Future events
and
actual results could differ materially from those set forth in, contemplated
by, or underlying the forward-looking statements. The risks and uncertainties to
which forward-looking statements are subject include, but are not limited to,
the
effect of government regulation, competition and other material risks.

    

Contact:
Stuart Fine
CEO
Carpe DM, Inc.
908-469-1788

Thomas Latino, PhD
Ludlow BioVentures
Phone: (201) 245-4278
Email: tlatino@ludlowcapital.com

Copyright 2008, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.